期刊文献+

Decreased Average Albumin-to-Globulin Ratio During Radiotherapy Worsens the Prognosis of Esophageal Squamous Cell Carcinoma:Implications for Nutritional Management 被引量:8

下载PDF
导出
摘要 Objective Malnutrition and cachexia are common in esophageal squamous cell carcinoma(ESCC)patients undergoing radiotherapy.This study evaluated how malnutrition-and cachexia-related indicators,including the albumin-to-globulin ratio(AGR),and their changes during radiotherapy predict the treatment outcomes.Methods We reviewed a total of 172 ESCC patients receiving radiotherapy(as a primary cohort)and performed a Cox regression analysis on potential prognostic factors,including the AGR,as well as the TNM stage and concomitant chemotherapy.A subsequent receiver operating characteristics(ROC)curve and Kaplan Meier survival analysis was performed for ESCC patients stratified by the average AGR cut-off point.Results In addition to the well-documented factors(i.e.TNM stage and concomitant chemotherapy),the average AGR was a significant prognostic factor for ESCC patients receiving radiotherapy.By plotting the ROC curve of the average AGR with regard to the ESCC prognosis,we obtained cut-off points for the overall patients(cut-off point:1.5,AUC:0.636),for patients with stageⅡ/Ⅲdisease(cut-off point:1.5,AUC:0.611),and for patients with stageⅣdisease(cut-off point:1.84,AUC:0.900).The ESCC patients with higher average AGR had a significantly more favorable OS compared with those with a lower average AGR.Notably,ESCC patients who had an increasingΔAGR during radiotherapy had a considerably more favorable OS compared with those with a decreasingΔAGR.All of these findings were reproducible in the validation cohort.Conclusion A lower average AGR is indicative of a poorer prognosis for ESCC patients following radiotherapy.Improving the nutritional status and preventing or ameliorating cachexia might contribute to improving the prognosis of ESCC patients.
出处 《Journal of Nutritional Oncology》 2021年第2期64-73,共10页 肿瘤营养学杂志(英文)
基金 This work was supported by grants from the Natural Science Foundation of Guangdong Province(2018A030307050) the National Natural Science Foundation of China(82071973) the Natural Science Foundation of Guangdong Province(2020A1515011022) the Department of Education of Guangdong Province(2017KTSCX071) the Special Fund for Science and Technology of Guangdong Province(190829105556145) the Special Fund for Science and Technology Innovation Strategy of Guangdong Province(180918114960704).
  • 相关文献

参考文献1

二级参考文献19

  • 1Jiang, Li,Yan, Lu-Nan.Current therapeutic strategies for recurrent hepatitis B virus infection after liver transplantation[J].World Journal of Gastroenterology,2010,16(20):2468-2475. 被引量:11
  • 2Pipsa Saharinen,Lauri Eklund,Kristina Pulkki,Petri Bono,Kari Alitalo.VEGF and angiopoietin signaling in tumor angiogenesis and metastasis[J]. Trends in Molecular Medicine . 2011 (7)
  • 3Valentina Rosa Bertuzzo,Matteo Cescon,Matteo Ravaioli,Gian Luca Grazi,Giorgio Ercolani,Massimo Del Gaudio,Alessandro Cucchetti,Antonietta D?Errico-Grigioni,Rita Golfieri,Antonio Daniele Pinna.Analysis of Factors Affecting Recurrence of Hepatocellular Carcinoma After Liver Transplantation With a Special Focus on Inflammation Markers[J]. Transplantation . 2011 (11)
  • 4Hideaki Shimada,Nobuhiro Takiguchi,Osamu Kainuma,Hiroaki Soda,Atsushi Ikeda,Akihiro Cho,Akinari Miyazaki,Hisashi Gunji,Hiroshi Yamamoto,Matsuo Nagata.High preoperative neutrophil-lymphocyte ratio predicts poor survival in patients with gastric cancer[J]. Gastric Cancer . 2010 (3)
  • 5E.Vibert,D.Azoulay,E.Hoti,S.Iacopinelli,D.Samuel,C.Salloum,A.Lemoine,H.Bismuth,D.Castaing,R.Adam.Progression of Alphafetoprotein Before Liver Transplantation for Hepatocellular Carcinoma in Cirrhotic Patients: A Critical Factor[J]. American Journal of Transplantation . 2009 (1)
  • 6Karim J. Halazun,Mark A. Hardy,Abbas A. Rana,David C. Woodland,Elijah J. Luyten,Suhari Mahadev,Piotr Witkowski,Abbey B. Siegel,Robert S. Brown,Jean C. Emond.Negative Impact of Neutrophil-Lymphocyte Ratio on Outcome After Liver Transplantation for Hepatocellular Carcinoma[J]. Annals of Surgery . 2009 (1)
  • 7Napoleone Ferrara.Pathways mediating VEGF-independent tumor angiogenesis[J]. Cytokine and Growth Factor Reviews . 2009 (1)
  • 8F. Y.Yao.Liver Transplantation for Hepatocellular Carcinoma: Beyond the Milan Criteria[J]. American Journal of Transplantation . 2008 (10)
  • 9John P. Duffy,Andrew Vardanian,Elizabeth Benjamin,Melissa Watson,Douglas G. Farmer,Rafik M. Ghobrial,Gerald Lipshutz,Hasan Yersiz,David S. K. Lu,Charles Lassman,Myron J. Tong,Jonathan R. Hiatt,Ronald W. Busuttil.Liver Transplantation Criteria For Hepatocellular Carcinoma Should Be Expanded: A 22-Year Experience With 467 Patients at UCLA[J]. Annals of Surgery . 2007 (3)
  • 10FlorianL?he,Martin KAngele,MarkusRentsch,ChristianGraeb,AlexanderGerbes,UdoL?hrs,UlrichBeuers,Karl‐WalterJauch.Multifocal manifestation does not affect vascular invasion of hepatocellular carcinoma: implications for patient selection in liver transplantation[J]. Clinical Transplantation . 2007 (6)

共引文献12

同被引文献59

引证文献8

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部